In addition to the clinical overlap between NF1 and Legius syndrome, at the biochemical level the SPRED1 protein interacts with neurofibromin, recruiting neurofibromin to the membrane and enabling Ras-GAP activity of neurofibromin and suppression of downstream ERK activation [23, 30]. The gene discussed is SPRED1; the disease is Legius syndrome.